{"id":"https://openalex.org/W2067443700","doi":"https://doi.org/10.1371/journal.pcbi.1000503","title":"Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib","display_name":"Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib","publication_year":2009,"publication_date":"2009-09-10","ids":{"openalex":"https://openalex.org/W2067443700","doi":"https://doi.org/10.1371/journal.pcbi.1000503","mag":"2067443700","pmid":"https://pubmed.ncbi.nlm.nih.gov/19749982"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pcbi.1000503","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pcbi.1000503","pdf_url":"https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1000503&type=printable","source":{"id":"https://openalex.org/S86033158","display_name":"PLoS Computational Biology","issn_l":"1553-734X","issn":["1553-734X","1553-7358"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS Computational Biology","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1000503&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035234146","display_name":"Jasmine Foo","orcid":"https://orcid.org/0000-0001-8238-325X"},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasmine Foo","raw_affiliation_strings":["Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America"],"affiliations":[{"raw_affiliation_string":"Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112197328","display_name":"Mark W. Drummond","orcid":null},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark W. Drummond","raw_affiliation_strings":["Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom"],"affiliations":[{"raw_affiliation_string":"Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111733827","display_name":"Bayard D. Clarkson","orcid":null},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bayard Clarkson","raw_affiliation_strings":["Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America"],"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047732858","display_name":"Tessa L. Holyoake","orcid":"https://orcid.org/0000-0002-0608-6066"},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tessa Holyoake","raw_affiliation_strings":["Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom"],"affiliations":[{"raw_affiliation_string":"Section of Experimental Haematology, Medical Faculty, University of Glasgow, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091861581","display_name":"Franziska Michor","orcid":"https://orcid.org/0009-0003-8552-7767"},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Franziska Michor","raw_affiliation_strings":["Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America"],"affiliations":[{"raw_affiliation_string":"Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5091861581"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":2655,"currency":"USD","value_usd":2655},"apc_paid":{"value":2655,"currency":"USD","value_usd":2655},"fwci":2.9115,"has_fulltext":true,"cited_by_count":67,"citation_normalized_percentile":{"value":0.91092608,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"5","issue":"9","first_page":"e1000503","last_page":"e1000503"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9937999844551086,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"Imatinib mesylate","score":0.8408249616622925},{"id":"https://openalex.org/keywords/imatinib","display_name":"Imatinib","score":0.8034905195236206},{"id":"https://openalex.org/keywords/stem-cell","display_name":"Stem cell","score":0.7737905979156494},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"Myeloid leukemia","score":0.7068158984184265},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.5834115147590637},{"id":"https://openalex.org/keywords/leukemia","display_name":"Leukemia","score":0.5435712933540344},{"id":"https://openalex.org/keywords/cancer-research","display_name":"Cancer research","score":0.5369424819946289},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"Granulocyte colony-stimulating factor","score":0.5342914462089539},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"Bone marrow","score":0.49578937888145447},{"id":"https://openalex.org/keywords/haematopoiesis","display_name":"Haematopoiesis","score":0.4794415533542633},{"id":"https://openalex.org/keywords/immunology","display_name":"Immunology","score":0.46243536472320557},{"id":"https://openalex.org/keywords/minimal-residual-disease","display_name":"Minimal residual disease","score":0.4512292146682739},{"id":"https://openalex.org/keywords/stem-cell-factor","display_name":"Stem cell factor","score":0.4324079155921936},{"id":"https://openalex.org/keywords/oncology","display_name":"Oncology","score":0.3362133502960205},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.32868492603302},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.2942813038825989},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.2632777690887451},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"Chemotherapy","score":0.2075059413909912},{"id":"https://openalex.org/keywords/cell-biology","display_name":"Cell biology","score":0.0657900869846344}],"concepts":[{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.8408249616622925},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8034905195236206},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.7737905979156494},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7068158984184265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5834115147590637},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5435712933540344},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5369424819946289},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5342914462089539},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.49578937888145447},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4794415533542633},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46243536472320557},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.4512292146682739},{"id":"https://openalex.org/C2022786","wikidata":"https://www.wikidata.org/wiki/Q909331","display_name":"Stem cell factor","level":4,"score":0.4324079155921936},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3362133502960205},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32868492603302},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2942813038825989},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2632777690887451},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2075059413909912},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0657900869846344}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1371/journal.pcbi.1000503","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pcbi.1000503","pdf_url":"https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1000503&type=printable","source":{"id":"https://openalex.org/S86033158","display_name":"PLoS Computational Biology","issn_l":"1553-734X","issn":["1553-734X","1553-7358"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS Computational Biology","raw_type":"journal-article"},{"id":"pmid:19749982","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19749982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS computational biology","raw_type":null},{"id":"pmh:oai:eprints.gla.ac.uk:18375","is_oa":false,"landing_page_url":"https://eprints.gla.ac.uk/view/author/10329.html>,","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"PeerReviewed"},{"id":"pmh:oai:doaj.org/article:a3a728b03e7e499091e3e993abeb518a","is_oa":true,"landing_page_url":"https://doaj.org/article/a3a728b03e7e499091e3e993abeb518a","pdf_url":null,"source":{"id":"https://openalex.org/S112646816","display_name":"SHILAP Revista de lepidopterolog\u00eda","issn_l":"0300-5267","issn":["0300-5267","2340-4078"],"is_oa":true,"is_in_doaj":true,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS Computational Biology, Vol 5, Iss 9, p e1000503 (2009)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/146425","is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Eradication_of_Chronic_Myeloid_Leukemia_Stem_Cells_A_Novel_Mathematical_Model_Predicts_No_Therapeutic_Benefit_of_Adding_G_CSF_to_Imatinib/146425","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:pubmedcentral.nih.gov:2730033","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2730033","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS Comput Biol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1371/journal.pcbi.1000503","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pcbi.1000503","pdf_url":"https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1000503&type=printable","source":{"id":"https://openalex.org/S86033158","display_name":"PLoS Computational Biology","issn_l":"1553-734X","issn":["1553-734X","1553-7358"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS Computational Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.800000011920929}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2067443700.pdf","grobid_xml":"https://content.openalex.org/works/W2067443700.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W46861897","https://openalex.org/W98258303","https://openalex.org/W105094313","https://openalex.org/W120597284","https://openalex.org/W1881821787","https://openalex.org/W1968034850","https://openalex.org/W1968071128","https://openalex.org/W1980473329","https://openalex.org/W1981631249","https://openalex.org/W1982106657","https://openalex.org/W1987239635","https://openalex.org/W1998593414","https://openalex.org/W1999277101","https://openalex.org/W1999614615","https://openalex.org/W2006765115","https://openalex.org/W2006917576","https://openalex.org/W2010473010","https://openalex.org/W2011819545","https://openalex.org/W2012962381","https://openalex.org/W2013315155","https://openalex.org/W2014316424","https://openalex.org/W2015616444","https://openalex.org/W2026389791","https://openalex.org/W2028085190","https://openalex.org/W2042694279","https://openalex.org/W2048385227","https://openalex.org/W2054520600","https://openalex.org/W2058564254","https://openalex.org/W2070154483","https://openalex.org/W2072384136","https://openalex.org/W2076791154","https://openalex.org/W2077264573","https://openalex.org/W2081834615","https://openalex.org/W2083530483","https://openalex.org/W2090982381","https://openalex.org/W2094556422","https://openalex.org/W2101390452","https://openalex.org/W2102085111","https://openalex.org/W2105495977","https://openalex.org/W2107984403","https://openalex.org/W2120223845","https://openalex.org/W2124082414","https://openalex.org/W2125326158","https://openalex.org/W2126235458","https://openalex.org/W2154856176","https://openalex.org/W2161408060","https://openalex.org/W2237792098","https://openalex.org/W2273971600","https://openalex.org/W2329648702","https://openalex.org/W2397114778","https://openalex.org/W2408132225","https://openalex.org/W2553072330","https://openalex.org/W4230721068"],"related_works":["https://openalex.org/W2002247001","https://openalex.org/W2123135404","https://openalex.org/W2070391470","https://openalex.org/W2161653304","https://openalex.org/W2149815987","https://openalex.org/W2091813747","https://openalex.org/W2121209161","https://openalex.org/W4232321243","https://openalex.org/W2407768420","https://openalex.org/W3149855996"],"abstract_inverted_index":{"Imatinib":[0],"mesylate":[1],"induces":[2],"complete":[3],"cytogenetic":[4],"responses":[5],"in":[6,20,74,78,141,146,209,232],"patients":[7,15,195,231],"with":[8,66,143,155,200],"chronic":[9],"myeloid":[10],"leukemia":[11],"(CML),":[12],"yet":[13],"many":[14],"have":[16,30],"detectable":[17],"BCR-ABL":[18],"transcripts":[19],"peripheral":[21],"blood":[22],"even":[23],"after":[24],"prolonged":[25],"therapy.":[26],"Bone":[27],"marrow":[28],"studies":[29],"shown":[31],"that":[32,104,165,221],"this":[33,81],"residual":[34],"disease":[35],"resides":[36],"within":[37],"the":[38,60,95,105,120,133,166,180,188,210,222,233],"stem":[39,45,76,90,124,185],"cell":[40,91,135],"compartment.":[41],"Quiescence":[42],"of":[43,89,107,122,168,175,182,207,225],"leukemic":[44,75,123,134,184],"cells":[46,77,125],"has":[47,68],"been":[48],"suggested":[49],"as":[50,213],"a":[51,71,85,147,172],"mechanism":[52],"conferring":[53],"insensitivity":[54],"to":[55,59,70,93,98,109,115,171,196,215,230],"imatinib,":[56,67],"and":[57,100],"exposure":[58],"Granulocyte-Colony":[61],"Stimulating":[62],"Factor":[63],"(G-CSF),":[64],"together":[65],"led":[69],"significant":[72],"reduction":[73],"vitro.":[79],"In":[80],"paper,":[82],"we":[83],"design":[84],"novel":[86],"mathematical":[87],"model":[88,163],"quiescence":[92],"investigate":[94],"treatment":[96,112],"response":[97],"imatinib":[99,111,151],"G-CSF.":[101],"We":[102],"find":[103],"addition":[106,167],"G-CSF":[108,158,169,226],"an":[110],"protocol":[113],"leads":[114,170],"observable":[116],"effects":[117],"only":[118],"if":[119],"majority":[121],"are":[126],"quiescent;":[127],"otherwise":[128],"it":[129,178],"does":[130],"not":[131,192],"modulate":[132],"burden.":[136],"The":[137],"latter":[138],"scenario":[139],"is":[140],"agreement":[142],"clinical":[144],"findings":[145],"pilot":[148,189],"study":[149,190],"administering":[150],"continuously":[152],"or":[153,156],"intermittently,":[154],"without":[157],"(GIMI":[159],"trial).":[160],"Furthermore,":[161],"our":[162],"predicts":[164],"higher":[173],"risk":[174],"resistance":[176],"since":[177],"increases":[179],"production":[181],"cycling":[183],"cells.":[186],"Although":[187],"did":[191],"include":[193],"enough":[194],"draw":[197],"any":[198],"conclusion":[199],"statistical":[201],"significance,":[202],"there":[203],"were":[204],"more":[205],"cases":[206],"progression":[208],"experimental":[211],"arms":[212],"compared":[214],"continuous":[216],"imatinib.":[217],"Our":[218],"results":[219],"suggest":[220],"additional":[223],"use":[224],"may":[227],"be":[228],"detrimental":[229],"clinic.":[234]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-04-21T08:09:41.155169","created_date":"2025-10-10T00:00:00"}